<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="marks" width="574" height="447" viewBox="0 0 574 447"><rect width="574" height="447" fill="white"/><g fill="none" stroke-miterlimit="10" transform="translate(64,87)"><g class="mark-group role-frame root" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h500v300h-500Z" stroke="lightgray" stroke-width="0.5"/><g><g class="mark-group role-axis" aria-hidden="true"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-grid" pointer-events="none"><line transform="translate(0,300)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,254)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,208)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,162)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,115)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,69)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,23)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="X-axis for a discrete scale with 13 values: 0, 1, 2, 3, 4, ending with 12"><g transform="translate(0.5,300.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(19,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(57,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(96,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(134,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(173,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(211,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(250,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(288,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(326,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(365,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(403,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(442,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(480,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(18.73076923076924,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">0</text><text text-anchor="end" transform="translate(57.1923076923077,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">1</text><text text-anchor="end" transform="translate(95.65384615384616,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">2</text><text text-anchor="end" transform="translate(134.11538461538464,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">3</text><text text-anchor="end" transform="translate(172.5769230769231,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">4</text><text text-anchor="end" transform="translate(211.03846153846155,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">5</text><text text-anchor="end" transform="translate(249.5,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">6</text><text text-anchor="end" transform="translate(287.9615384615385,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">7</text><text text-anchor="end" transform="translate(326.42307692307696,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">8</text><text text-anchor="end" transform="translate(364.8846153846154,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">9</text><text text-anchor="end" transform="translate(403.34615384615387,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">10</text><text text-anchor="end" transform="translate(441.8076923076923,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">11</text><text text-anchor="end" transform="translate(480.2692307692308,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">12</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,0)" x2="500" y2="0" stroke="black" stroke-width="0.5" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="Y-axis titled 'Number of Participants' for a linear scale with values from 0 to 130"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(0,300)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,254)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,208)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,162)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,115)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,69)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,23)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(-7,303)" font-family="Arial" font-size="11px" fill="black" opacity="1">0</text><text text-anchor="end" transform="translate(-7,256.8461538461538)" font-family="Arial" font-size="11px" fill="black" opacity="1">20</text><text text-anchor="end" transform="translate(-7,210.69230769230768)" font-family="Arial" font-size="11px" fill="black" opacity="1">40</text><text text-anchor="end" transform="translate(-7,164.53846153846152)" font-family="Arial" font-size="11px" fill="black" opacity="1">60</text><text text-anchor="end" transform="translate(-7,118.38461538461537)" font-family="Arial" font-size="11px" fill="black" opacity="1">80</text><text text-anchor="end" transform="translate(-7,72.23076923076921)" font-family="Arial" font-size="11px" fill="black" opacity="1">100</text><text text-anchor="end" transform="translate(-7,26.076923076923062)" font-family="Arial" font-size="11px" fill="black" opacity="1">120</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,300)" x2="0" y2="-300" stroke="black" stroke-width="0.5" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(-40.35302734375,150) rotate(-90) translate(0,-3)" font-family="Arial" font-size="12px" font-weight="bold" fill="black" opacity="1">Number of Participants</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-rect role-mark layer_0_marks" role="graphics-object" aria-roledescription="rect mark container"><path aria-label="Stage: 0; Number of Participants: 59; Diagnosis: CN; Count: 59; Percentage: 47.2%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,163.84615384615387h34.61538461538461v136.15384615384613h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 0; Number of Participants: 47; Diagnosis: EMCI; Count: 47; Percentage: 37.6%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,55.38461538461539h34.61538461538461v108.46153846153848h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 0; Number of Participants: 19; Diagnosis: LMCI; Count: 19; Percentage: 15.2%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,11.538461538461531h34.61538461538461v43.846153846153854h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 0; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 1; Number of Participants: 17; Diagnosis: CN; Count: 17; Percentage: 40.5%" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,260.7692307692308h34.61538461538461v39.230769230769226h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 1; Number of Participants: 12; Diagnosis: EMCI; Count: 12; Percentage: 28.6%" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,233.0769230769231h34.61538461538461v27.69230769230768h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 1; Number of Participants: 13; Diagnosis: LMCI; Count: 13; Percentage: 31.0%" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,203.0769230769231h34.61538461538461v30h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 1; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 2; Number of Participants: 40; Diagnosis: CN; Count: 40; Percentage: 59.7%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,207.69230769230768h34.61538461538461v92.30769230769232h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 2; Number of Participants: 21; Diagnosis: EMCI; Count: 21; Percentage: 31.3%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,159.23076923076923h34.61538461538461v48.46153846153845h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 2; Number of Participants: 6; Diagnosis: LMCI; Count: 6; Percentage: 9.0%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,145.38461538461542h34.61538461538461v13.846153846153811h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 2; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 3; Number of Participants: 15; Diagnosis: CN; Count: 15; Percentage: 51.7%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,265.38461538461536h34.61538461538461v34.61538461538464h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 3; Number of Participants: 9; Diagnosis: EMCI; Count: 9; Percentage: 31.0%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,244.6153846153846h34.61538461538461v20.769230769230745h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 3; Number of Participants: 5; Diagnosis: LMCI; Count: 5; Percentage: 17.2%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,233.0769230769231h34.61538461538461v11.538461538461519h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 3; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 4; Number of Participants: 3; Diagnosis: CN; Count: 3; Percentage: 11.1%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,293.0769230769231h34.61538461538461v6.923076923076906h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 4; Number of Participants: 16; Diagnosis: EMCI; Count: 16; Percentage: 59.3%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,256.15384615384613h34.61538461538461v36.92307692307696h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 4; Number of Participants: 8; Diagnosis: LMCI; Count: 8; Percentage: 29.6%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,237.69230769230768h34.61538461538461v18.461538461538453h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 4; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 5; Number of Participants: 1; Diagnosis: CN; Count: 1; Percentage: 2.9%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,297.6923076923077h34.61538461538461v2.307692307692321h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 5; Number of Participants: 16; Diagnosis: EMCI; Count: 16; Percentage: 45.7%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,260.7692307692308h34.61538461538461v36.923076923076906h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 5; Number of Participants: 18; Diagnosis: LMCI; Count: 18; Percentage: 51.4%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,219.23076923076925h34.61538461538461v41.53846153846152h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 5; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 6; Number of Participants: 3; Diagnosis: CN; Count: 3; Percentage: 4.8%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,251.53846153846155h34.61538461538461v6.923076923076906h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 6; Number of Participants: 14; Diagnosis: EMCI; Count: 14; Percentage: 22.2%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,219.23076923076925h34.61538461538461v32.30769230769229h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 6; Number of Participants: 28; Diagnosis: LMCI; Count: 28; Percentage: 44.4%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,154.61538461538458h34.61538461538461v64.61538461538467h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 6; Number of Participants: 18; Diagnosis: AD; Count: 18; Percentage: 28.6%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,258.46153846153845h34.61538461538461v41.53846153846155h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 7; Number of Participants: 2; Diagnosis: CN; Count: 2; Percentage: 20.0%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,293.0769230769231h34.61538461538461v4.615384615384585h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 7; Number of Participants: 1; Diagnosis: EMCI; Count: 1; Percentage: 10.0%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,290.7692307692308h34.61538461538461v2.307692307692321h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 7; Number of Participants: 6; Diagnosis: LMCI; Count: 6; Percentage: 60.0%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,276.92307692307696h34.61538461538461v13.846153846153811h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 7; Number of Participants: 1; Diagnosis: AD; Count: 1; Percentage: 10.0%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,297.6923076923077h34.61538461538461v2.307692307692321h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 8; Number of Participants: 9; Diagnosis: CN; Count: 9; Percentage: 11.7%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,249.2307692307692h34.61538461538461v20.769230769230802h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 8; Number of Participants: 20; Diagnosis: EMCI; Count: 20; Percentage: 26.0%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,203.0769230769231h34.61538461538461v46.153846153846104h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 8; Number of Participants: 35; Diagnosis: LMCI; Count: 35; Percentage: 45.5%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,122.3076923076923h34.61538461538461v80.76923076923079h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 8; Number of Participants: 13; Diagnosis: AD; Count: 13; Percentage: 16.9%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,270h34.61538461538461v30h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 9; Number of Participants: 3; Diagnosis: CN; Count: 3; Percentage: 9.4%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,272.3076923076923h34.61538461538461v6.923076923076906h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 9; Number of Participants: 8; Diagnosis: EMCI; Count: 8; Percentage: 25.0%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,253.84615384615384h34.61538461538461v18.46153846153848h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 9; Number of Participants: 12; Diagnosis: LMCI; Count: 12; Percentage: 37.5%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,226.15384615384616h34.61538461538461v27.69230769230768h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 9; Number of Participants: 9; Diagnosis: AD; Count: 9; Percentage: 28.1%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,279.2307692307692h34.61538461538461v20.769230769230774h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 10; Number of Participants: 2; Diagnosis: CN; Count: 2; Percentage: 2.6%" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,212.3076923076923h34.61538461538461v4.615384615384613h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 10; Number of Participants: 9; Diagnosis: EMCI; Count: 9; Percentage: 11.5%" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,191.53846153846152h34.61538461538461v20.769230769230774h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 10; Number of Participants: 31; Diagnosis: LMCI; Count: 31; Percentage: 39.7%" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,120h34.61538461538461v71.53846153846152h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 10; Number of Participants: 36; Diagnosis: AD; Count: 36; Percentage: 46.2%" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,216.9230769230769h34.61538461538461v83.0769230769231h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 11; Number of Participants: 1; Diagnosis: CN; Count: 1; Percentage: 1.4%" role="graphics-symbol" aria-roledescription="bar" d="M425,212.3076923076923h34.61538461538461v2.307692307692321h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 11; Number of Participants: 2; Diagnosis: EMCI; Count: 2; Percentage: 2.8%" role="graphics-symbol" aria-roledescription="bar" d="M425,207.69230769230768h34.61538461538461v4.615384615384613h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 11; Number of Participants: 32; Diagnosis: LMCI; Count: 32; Percentage: 44.4%" role="graphics-symbol" aria-roledescription="bar" d="M425,133.84615384615384h34.61538461538461v73.84615384615384h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 11; Number of Participants: 37; Diagnosis: AD; Count: 37; Percentage: 51.4%" role="graphics-symbol" aria-roledescription="bar" d="M425,214.6153846153846h34.61538461538461v85.38461538461539h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 12; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,210h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 12; Number of Participants: 7; Diagnosis: EMCI; Count: 7; Percentage: 10.1%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,193.8461538461538h34.61538461538461v16.15384615384619h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 12; Number of Participants: 23; Diagnosis: LMCI; Count: 23; Percentage: 33.3%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,140.76923076923077h34.61538461538461v53.07692307692304h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 12; Number of Participants: 39; Diagnosis: AD; Count: 39; Percentage: 56.5%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,210h34.61538461538461v90h-34.61538461538461Z" fill="#EE6677"/></g><g class="mark-text role-mark layer_1_marks" role="graphics-object" aria-roledescription="text mark container"><text aria-label="Stage: 0; Total: 125; Total Sample Size: 125" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">125</text><text aria-label="Stage: 0; Total: 125; Total Sample Size: 125" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">125</text><text aria-label="Stage: 0; Total: 125; Total Sample Size: 125" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">125</text><text aria-label="Stage: 0; Total: 125; Total Sample Size: 125" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">125</text><text aria-label="Stage: 1; Total: 42; Total Sample Size: 42" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">42</text><text aria-label="Stage: 1; Total: 42; Total Sample Size: 42" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">42</text><text aria-label="Stage: 1; Total: 42; Total Sample Size: 42" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">42</text><text aria-label="Stage: 1; Total: 42; Total Sample Size: 42" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">42</text><text aria-label="Stage: 2; Total: 67; Total Sample Size: 67" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">67</text><text aria-label="Stage: 2; Total: 67; Total Sample Size: 67" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">67</text><text aria-label="Stage: 2; Total: 67; Total Sample Size: 67" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">67</text><text aria-label="Stage: 2; Total: 67; Total Sample Size: 67" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">67</text><text aria-label="Stage: 3; Total: 29; Total Sample Size: 29" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">29</text><text aria-label="Stage: 3; Total: 29; Total Sample Size: 29" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">29</text><text aria-label="Stage: 3; Total: 29; Total Sample Size: 29" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">29</text><text aria-label="Stage: 3; Total: 29; Total Sample Size: 29" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">29</text><text aria-label="Stage: 4; Total: 27; Total Sample Size: 27" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">27</text><text aria-label="Stage: 4; Total: 27; Total Sample Size: 27" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">27</text><text aria-label="Stage: 4; Total: 27; Total Sample Size: 27" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">27</text><text aria-label="Stage: 4; Total: 27; Total Sample Size: 27" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">27</text><text aria-label="Stage: 5; Total: 35; Total Sample Size: 35" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">35</text><text aria-label="Stage: 5; Total: 35; Total Sample Size: 35" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">35</text><text aria-label="Stage: 5; Total: 35; Total Sample Size: 35" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">35</text><text aria-label="Stage: 5; Total: 35; Total Sample Size: 35" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">35</text><text aria-label="Stage: 6; Total: 63; Total Sample Size: 63" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">63</text><text aria-label="Stage: 6; Total: 63; Total Sample Size: 63" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">63</text><text aria-label="Stage: 6; Total: 63; Total Sample Size: 63" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">63</text><text aria-label="Stage: 6; Total: 63; Total Sample Size: 63" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">63</text><text aria-label="Stage: 7; Total: 10; Total Sample Size: 10" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">10</text><text aria-label="Stage: 7; Total: 10; Total Sample Size: 10" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">10</text><text aria-label="Stage: 7; Total: 10; Total Sample Size: 10" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">10</text><text aria-label="Stage: 7; Total: 10; Total Sample Size: 10" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">10</text><text aria-label="Stage: 8; Total: 77; Total Sample Size: 77" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">77</text><text aria-label="Stage: 8; Total: 77; Total Sample Size: 77" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">77</text><text aria-label="Stage: 8; Total: 77; Total Sample Size: 77" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">77</text><text aria-label="Stage: 8; Total: 77; Total Sample Size: 77" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">77</text><text aria-label="Stage: 9; Total: 32; Total Sample Size: 32" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">32</text><text aria-label="Stage: 9; Total: 32; Total Sample Size: 32" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">32</text><text aria-label="Stage: 9; Total: 32; Total Sample Size: 32" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">32</text><text aria-label="Stage: 9; Total: 32; Total Sample Size: 32" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">32</text><text aria-label="Stage: 10; Total: 78; Total Sample Size: 78" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">78</text><text aria-label="Stage: 10; Total: 78; Total Sample Size: 78" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">78</text><text aria-label="Stage: 10; Total: 78; Total Sample Size: 78" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">78</text><text aria-label="Stage: 10; Total: 78; Total Sample Size: 78" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">78</text><text aria-label="Stage: 11; Total: 72; Total Sample Size: 72" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">72</text><text aria-label="Stage: 11; Total: 72; Total Sample Size: 72" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">72</text><text aria-label="Stage: 11; Total: 72; Total Sample Size: 72" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">72</text><text aria-label="Stage: 11; Total: 72; Total Sample Size: 72" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">72</text><text aria-label="Stage: 12; Total: 69; Total Sample Size: 69" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">69</text><text aria-label="Stage: 12; Total: 69; Total Sample Size: 69" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">69</text><text aria-label="Stage: 12; Total: 69; Total Sample Size: 69" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">69</text><text aria-label="Stage: 12; Total: 69; Total Sample Size: 69" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">69</text></g><g class="mark-group role-legend" role="graphics-symbol" aria-roledescription="legend" aria-label="Symbol legend for fill color with 4 values: CN, EMCI, LMCI, AD"><g transform="translate(0,-29)"><path class="background" aria-hidden="true" d="M0,0h181v11h-181Z" pointer-events="none"/><g><g class="mark-group role-legend-entry"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-group role-scope" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h31.8876953125v11h-31.8876953125Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#4477AA" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">CN</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(42,0)"><path class="background" aria-hidden="true" d="M0,0h43.5v11h-43.5Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#66CCEE" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">EMCI</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(96,0)"><path class="background" aria-hidden="true" d="M0,0h42.28076171875v11h-42.28076171875Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#228833" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">LMCI</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(149,0)"><path class="background" aria-hidden="true" d="M0,0h31.28076171875v11h-31.28076171875Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#EE6677" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">AD</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-title"><g transform="translate(250,-47)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-text role-title-text" role="graphics-symbol" aria-roledescription="title" aria-label="Title text 'Distribution of Disease Stages by Diagnosis, UCL GMM'" pointer-events="none"><text text-anchor="middle" transform="translate(0,1)" font-family="sans-serif" font-size="14px" font-weight="normal" fill="#000" opacity="1">Distribution of Disease Stages by Diagnosis, UCL GMM</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g></g></svg>